nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefprozil—Toxic epidermal necrolysis—Paclitaxel—kidney cancer	0.00318	0.00318	CcSEcCtD
Cefprozil—Erythema—Sunitinib—kidney cancer	0.00316	0.00316	CcSEcCtD
Cefprozil—Abdominal pain—Pazopanib—kidney cancer	0.00309	0.00309	CcSEcCtD
Cefprozil—Dermatitis exfoliative—Capecitabine—kidney cancer	0.00307	0.00307	CcSEcCtD
Cefprozil—Hypersensitivity—Temsirolimus—kidney cancer	0.00306	0.00306	CcSEcCtD
Cefprozil—Thrombocytopenia—Vinblastine—kidney cancer	0.00304	0.00304	CcSEcCtD
Cefprozil—Agranulocytosis—Gemcitabine—kidney cancer	0.00303	0.00303	CcSEcCtD
Cefprozil—Thrombocytopenia—Everolimus—kidney cancer	0.00303	0.00303	CcSEcCtD
Cefprozil—Angioedema—Sorafenib—kidney cancer	0.003	0.003	CcSEcCtD
Cefprozil—Erythema—Dactinomycin—kidney cancer	0.00299	0.00299	CcSEcCtD
Cefprozil—Pruritus—Temsirolimus—kidney cancer	0.00294	0.00294	CcSEcCtD
Cefprozil—Haemoglobin—Gemcitabine—kidney cancer	0.00293	0.00293	CcSEcCtD
Cefprozil—Jaundice cholestatic—Doxorubicin—kidney cancer	0.00293	0.00293	CcSEcCtD
Cefprozil—Thrombocytopenia—Erlotinib—kidney cancer	0.00292	0.00292	CcSEcCtD
Cefprozil—Haemorrhage—Gemcitabine—kidney cancer	0.00291	0.00291	CcSEcCtD
Cefprozil—Pancytopenia—Paclitaxel—kidney cancer	0.0029	0.0029	CcSEcCtD
Cefprozil—Pharyngitis—Gemcitabine—kidney cancer	0.00289	0.00289	CcSEcCtD
Cefprozil—Angioedema—Sunitinib—kidney cancer	0.00289	0.00289	CcSEcCtD
Cefprozil—Neutropenia—Paclitaxel—kidney cancer	0.00285	0.00285	CcSEcCtD
Cefprozil—Diarrhoea—Temsirolimus—kidney cancer	0.00284	0.00284	CcSEcCtD
Cefprozil—Insomnia—Everolimus—kidney cancer	0.00279	0.00279	CcSEcCtD
Cefprozil—Pruritus—Pazopanib—kidney cancer	0.00277	0.00277	CcSEcCtD
Cefprozil—Erythema multiforme—Gemcitabine—kidney cancer	0.00276	0.00276	CcSEcCtD
Cefprozil—Somnolence—Everolimus—kidney cancer	0.00275	0.00275	CcSEcCtD
Cefprozil—Dizziness—Temsirolimus—kidney cancer	0.00275	0.00275	CcSEcCtD
Cefprozil—Convulsion—Sunitinib—kidney cancer	0.00274	0.00274	CcSEcCtD
Cefprozil—Insomnia—Erlotinib—kidney cancer	0.0027	0.0027	CcSEcCtD
Cefprozil—Stevens-Johnson syndrome—Paclitaxel—kidney cancer	0.0027	0.0027	CcSEcCtD
Cefprozil—Anaphylactic shock—Sorafenib—kidney cancer	0.00268	0.00268	CcSEcCtD
Cefprozil—Diarrhoea—Pazopanib—kidney cancer	0.00268	0.00268	CcSEcCtD
Cefprozil—Pain—Vinblastine—kidney cancer	0.00265	0.00265	CcSEcCtD
Cefprozil—Pain—Everolimus—kidney cancer	0.00264	0.00264	CcSEcCtD
Cefprozil—Vomiting—Temsirolimus—kidney cancer	0.00264	0.00264	CcSEcCtD
Cefprozil—Thrombocytopenia—Sorafenib—kidney cancer	0.00263	0.00263	CcSEcCtD
Cefprozil—Rash—Temsirolimus—kidney cancer	0.00262	0.00262	CcSEcCtD
Cefprozil—Dermatitis—Temsirolimus—kidney cancer	0.00262	0.00262	CcSEcCtD
Cefprozil—Toxic epidermal necrolysis—Capecitabine—kidney cancer	0.00261	0.00261	CcSEcCtD
Cefprozil—Headache—Temsirolimus—kidney cancer	0.0026	0.0026	CcSEcCtD
Cefprozil—Dizziness—Pazopanib—kidney cancer	0.00259	0.00259	CcSEcCtD
Cefprozil—Vaginal inflammation—Doxorubicin—kidney cancer	0.00257	0.00257	CcSEcCtD
Cefprozil—Feeling abnormal—Vinblastine—kidney cancer	0.00256	0.00256	CcSEcCtD
Cefprozil—Pain—Erlotinib—kidney cancer	0.00255	0.00255	CcSEcCtD
Cefprozil—Feeling abnormal—Everolimus—kidney cancer	0.00255	0.00255	CcSEcCtD
Cefprozil—Erythema—Gemcitabine—kidney cancer	0.00254	0.00254	CcSEcCtD
Cefprozil—Gastrointestinal pain—Vinblastine—kidney cancer	0.00254	0.00254	CcSEcCtD
Cefprozil—Thrombocytopenia—Sunitinib—kidney cancer	0.00253	0.00253	CcSEcCtD
Cefprozil—Gastrointestinal pain—Everolimus—kidney cancer	0.00253	0.00253	CcSEcCtD
Cefprozil—Vomiting—Pazopanib—kidney cancer	0.00249	0.00249	CcSEcCtD
Cefprozil—Colitis—Doxorubicin—kidney cancer	0.00247	0.00247	CcSEcCtD
Cefprozil—Rash—Pazopanib—kidney cancer	0.00247	0.00247	CcSEcCtD
Cefprozil—Nausea—Temsirolimus—kidney cancer	0.00247	0.00247	CcSEcCtD
Cefprozil—Dermatitis—Pazopanib—kidney cancer	0.00247	0.00247	CcSEcCtD
Cefprozil—Agitation—Vincristine—kidney cancer	0.00246	0.00246	CcSEcCtD
Cefprozil—Haemoglobin—Paclitaxel—kidney cancer	0.00245	0.00245	CcSEcCtD
Cefprozil—Abdominal pain—Vinblastine—kidney cancer	0.00245	0.00245	CcSEcCtD
Cefprozil—Headache—Pazopanib—kidney cancer	0.00245	0.00245	CcSEcCtD
Cefprozil—Abdominal pain—Everolimus—kidney cancer	0.00244	0.00244	CcSEcCtD
Cefprozil—Body temperature increased—Everolimus—kidney cancer	0.00244	0.00244	CcSEcCtD
Cefprozil—Haemorrhage—Paclitaxel—kidney cancer	0.00244	0.00244	CcSEcCtD
Cefprozil—Gastrointestinal pain—Erlotinib—kidney cancer	0.00244	0.00244	CcSEcCtD
Cefprozil—Blood urea increased—Doxorubicin—kidney cancer	0.00243	0.00243	CcSEcCtD
Cefprozil—Vaginal infection—Doxorubicin—kidney cancer	0.00243	0.00243	CcSEcCtD
Cefprozil—Pharyngitis—Paclitaxel—kidney cancer	0.00242	0.00242	CcSEcCtD
Cefprozil—Aplastic anaemia—Doxorubicin—kidney cancer	0.00241	0.00241	CcSEcCtD
Cefprozil—Thrombocytopenia—Dactinomycin—kidney cancer	0.00239	0.00239	CcSEcCtD
Cefprozil—Pancytopenia—Capecitabine—kidney cancer	0.00238	0.00238	CcSEcCtD
Cefprozil—Abdominal pain—Erlotinib—kidney cancer	0.00236	0.00236	CcSEcCtD
Cefprozil—Body temperature increased—Erlotinib—kidney cancer	0.00236	0.00236	CcSEcCtD
Cefprozil—Neutropenia—Capecitabine—kidney cancer	0.00234	0.00234	CcSEcCtD
Cefprozil—Insomnia—Sunitinib—kidney cancer	0.00233	0.00233	CcSEcCtD
Cefprozil—Nausea—Pazopanib—kidney cancer	0.00232	0.00232	CcSEcCtD
Cefprozil—Convulsion—Vincristine—kidney cancer	0.00232	0.00232	CcSEcCtD
Cefprozil—Erythema multiforme—Paclitaxel—kidney cancer	0.00231	0.00231	CcSEcCtD
Cefprozil—Pain—Sorafenib—kidney cancer	0.00229	0.00229	CcSEcCtD
Cefprozil—Hypersensitivity—Vinblastine—kidney cancer	0.00229	0.00229	CcSEcCtD
Cefprozil—Hypersensitivity—Everolimus—kidney cancer	0.00228	0.00228	CcSEcCtD
Cefprozil—Stevens-Johnson syndrome—Capecitabine—kidney cancer	0.00221	0.00221	CcSEcCtD
Cefprozil—Pain—Sunitinib—kidney cancer	0.00221	0.00221	CcSEcCtD
Cefprozil—Gastrointestinal pain—Sorafenib—kidney cancer	0.00219	0.00219	CcSEcCtD
Cefprozil—Pruritus—Everolimus—kidney cancer	0.00219	0.00219	CcSEcCtD
Cefprozil—Anaphylactic shock—Vincristine—kidney cancer	0.00218	0.00218	CcSEcCtD
Cefprozil—Thrombocytopenia—Vincristine—kidney cancer	0.00214	0.00214	CcSEcCtD
Cefprozil—Urticaria—Sorafenib—kidney cancer	0.00213	0.00213	CcSEcCtD
Cefprozil—Erythema—Paclitaxel—kidney cancer	0.00212	0.00212	CcSEcCtD
Cefprozil—Diarrhoea—Vinblastine—kidney cancer	0.00212	0.00212	CcSEcCtD
Cefprozil—Abdominal pain—Sorafenib—kidney cancer	0.00212	0.00212	CcSEcCtD
Cefprozil—Body temperature increased—Sorafenib—kidney cancer	0.00212	0.00212	CcSEcCtD
Cefprozil—Diarrhoea—Everolimus—kidney cancer	0.00211	0.00211	CcSEcCtD
Cefprozil—Gastrointestinal pain—Sunitinib—kidney cancer	0.00211	0.00211	CcSEcCtD
Cefprozil—Pruritus—Erlotinib—kidney cancer	0.00211	0.00211	CcSEcCtD
Cefprozil—Pain—Dactinomycin—kidney cancer	0.00209	0.00209	CcSEcCtD
Cefprozil—Tension—Paclitaxel—kidney cancer	0.00208	0.00208	CcSEcCtD
Cefprozil—Agranulocytosis—Capecitabine—kidney cancer	0.00208	0.00208	CcSEcCtD
Cefprozil—Anaphylactic shock—Gemcitabine—kidney cancer	0.00207	0.00207	CcSEcCtD
Cefprozil—Nervousness—Paclitaxel—kidney cancer	0.00206	0.00206	CcSEcCtD
Cefprozil—Dizziness—Vinblastine—kidney cancer	0.00205	0.00205	CcSEcCtD
Cefprozil—Dizziness—Everolimus—kidney cancer	0.00204	0.00204	CcSEcCtD
Cefprozil—Abdominal pain—Sunitinib—kidney cancer	0.00204	0.00204	CcSEcCtD
Cefprozil—Body temperature increased—Sunitinib—kidney cancer	0.00204	0.00204	CcSEcCtD
Cefprozil—Diarrhoea—Erlotinib—kidney cancer	0.00204	0.00204	CcSEcCtD
Cefprozil—Thrombocytopenia—Gemcitabine—kidney cancer	0.00203	0.00203	CcSEcCtD
Cefprozil—Feeling abnormal—Dactinomycin—kidney cancer	0.00201	0.00201	CcSEcCtD
Cefprozil—Haemoglobin—Capecitabine—kidney cancer	0.00201	0.00201	CcSEcCtD
Cefprozil—Haemorrhage—Capecitabine—kidney cancer	0.002	0.002	CcSEcCtD
Cefprozil—Gastrointestinal pain—Dactinomycin—kidney cancer	0.002	0.002	CcSEcCtD
Cefprozil—Pharyngitis—Capecitabine—kidney cancer	0.00199	0.00199	CcSEcCtD
Cefprozil—Dermatitis exfoliative—Doxorubicin—kidney cancer	0.00198	0.00198	CcSEcCtD
Cefprozil—Hypersensitivity—Sorafenib—kidney cancer	0.00198	0.00198	CcSEcCtD
Cefprozil—Insomnia—Vincristine—kidney cancer	0.00197	0.00197	CcSEcCtD
Cefprozil—Vomiting—Vinblastine—kidney cancer	0.00197	0.00197	CcSEcCtD
Cefprozil—Dizziness—Erlotinib—kidney cancer	0.00197	0.00197	CcSEcCtD
Cefprozil—Vomiting—Everolimus—kidney cancer	0.00196	0.00196	CcSEcCtD
Cefprozil—Agitation—Paclitaxel—kidney cancer	0.00195	0.00195	CcSEcCtD
Cefprozil—Rash—Everolimus—kidney cancer	0.00195	0.00195	CcSEcCtD
Cefprozil—Dermatitis—Everolimus—kidney cancer	0.00195	0.00195	CcSEcCtD
Cefprozil—Headache—Vinblastine—kidney cancer	0.00194	0.00194	CcSEcCtD
Cefprozil—Angioedema—Paclitaxel—kidney cancer	0.00194	0.00194	CcSEcCtD
Cefprozil—Headache—Everolimus—kidney cancer	0.00194	0.00194	CcSEcCtD
Cefprozil—Body temperature increased—Dactinomycin—kidney cancer	0.00193	0.00193	CcSEcCtD
Cefprozil—Abdominal pain—Dactinomycin—kidney cancer	0.00193	0.00193	CcSEcCtD
Cefprozil—Hypersensitivity—Sunitinib—kidney cancer	0.0019	0.0019	CcSEcCtD
Cefprozil—Pruritus—Sorafenib—kidney cancer	0.0019	0.0019	CcSEcCtD
Cefprozil—Vomiting—Erlotinib—kidney cancer	0.0019	0.0019	CcSEcCtD
Cefprozil—Erythema multiforme—Capecitabine—kidney cancer	0.00189	0.00189	CcSEcCtD
Cefprozil—Rash—Erlotinib—kidney cancer	0.00188	0.00188	CcSEcCtD
Cefprozil—Dermatitis—Erlotinib—kidney cancer	0.00188	0.00188	CcSEcCtD
Cefprozil—Insomnia—Gemcitabine—kidney cancer	0.00187	0.00187	CcSEcCtD
Cefprozil—Headache—Erlotinib—kidney cancer	0.00187	0.00187	CcSEcCtD
Cefprozil—Pain—Vincristine—kidney cancer	0.00187	0.00187	CcSEcCtD
Cefprozil—Nausea—Vinblastine—kidney cancer	0.00184	0.00184	CcSEcCtD
Cefprozil—Somnolence—Gemcitabine—kidney cancer	0.00184	0.00184	CcSEcCtD
Cefprozil—Convulsion—Paclitaxel—kidney cancer	0.00184	0.00184	CcSEcCtD
Cefprozil—Nausea—Everolimus—kidney cancer	0.00184	0.00184	CcSEcCtD
Cefprozil—Diarrhoea—Sorafenib—kidney cancer	0.00184	0.00184	CcSEcCtD
Cefprozil—Pruritus—Sunitinib—kidney cancer	0.00183	0.00183	CcSEcCtD
Cefprozil—Hypersensitivity—Dactinomycin—kidney cancer	0.0018	0.0018	CcSEcCtD
Cefprozil—Gastrointestinal pain—Vincristine—kidney cancer	0.00179	0.00179	CcSEcCtD
Cefprozil—Dizziness—Sorafenib—kidney cancer	0.00177	0.00177	CcSEcCtD
Cefprozil—Pain—Gemcitabine—kidney cancer	0.00177	0.00177	CcSEcCtD
Cefprozil—Nausea—Erlotinib—kidney cancer	0.00177	0.00177	CcSEcCtD
Cefprozil—Diarrhoea—Sunitinib—kidney cancer	0.00177	0.00177	CcSEcCtD
Cefprozil—Confusional state—Paclitaxel—kidney cancer	0.00175	0.00175	CcSEcCtD
Cefprozil—Erythema—Capecitabine—kidney cancer	0.00174	0.00174	CcSEcCtD
Cefprozil—Anaphylactic shock—Paclitaxel—kidney cancer	0.00173	0.00173	CcSEcCtD
Cefprozil—Abdominal pain—Vincristine—kidney cancer	0.00173	0.00173	CcSEcCtD
Cefprozil—Body temperature increased—Vincristine—kidney cancer	0.00173	0.00173	CcSEcCtD
Cefprozil—Dizziness—Sunitinib—kidney cancer	0.00171	0.00171	CcSEcCtD
Cefprozil—Feeling abnormal—Gemcitabine—kidney cancer	0.00171	0.00171	CcSEcCtD
Cefprozil—Vomiting—Sorafenib—kidney cancer	0.00171	0.00171	CcSEcCtD
Cefprozil—Thrombocytopenia—Paclitaxel—kidney cancer	0.0017	0.0017	CcSEcCtD
Cefprozil—Rash—Sorafenib—kidney cancer	0.00169	0.00169	CcSEcCtD
Cefprozil—Dermatitis—Sorafenib—kidney cancer	0.00169	0.00169	CcSEcCtD
Cefprozil—Toxic epidermal necrolysis—Doxorubicin—kidney cancer	0.00168	0.00168	CcSEcCtD
Cefprozil—Headache—Sorafenib—kidney cancer	0.00168	0.00168	CcSEcCtD
Cefprozil—Diarrhoea—Dactinomycin—kidney cancer	0.00167	0.00167	CcSEcCtD
Cefprozil—Vomiting—Sunitinib—kidney cancer	0.00164	0.00164	CcSEcCtD
Cefprozil—Body temperature increased—Gemcitabine—kidney cancer	0.00164	0.00164	CcSEcCtD
Cefprozil—Rash—Sunitinib—kidney cancer	0.00163	0.00163	CcSEcCtD
Cefprozil—Dermatitis—Sunitinib—kidney cancer	0.00163	0.00163	CcSEcCtD
Cefprozil—Headache—Sunitinib—kidney cancer	0.00162	0.00162	CcSEcCtD
Cefprozil—Hypersensitivity—Vincristine—kidney cancer	0.00161	0.00161	CcSEcCtD
Cefprozil—Eosinophilia—Doxorubicin—kidney cancer	0.0016	0.0016	CcSEcCtD
Cefprozil—Nausea—Sorafenib—kidney cancer	0.00159	0.00159	CcSEcCtD
Cefprozil—Insomnia—Paclitaxel—kidney cancer	0.00157	0.00157	CcSEcCtD
Cefprozil—Vomiting—Dactinomycin—kidney cancer	0.00155	0.00155	CcSEcCtD
Cefprozil—Somnolence—Paclitaxel—kidney cancer	0.00154	0.00154	CcSEcCtD
Cefprozil—Rash—Dactinomycin—kidney cancer	0.00154	0.00154	CcSEcCtD
Cefprozil—Nausea—Sunitinib—kidney cancer	0.00153	0.00153	CcSEcCtD
Cefprozil—Pancytopenia—Doxorubicin—kidney cancer	0.00153	0.00153	CcSEcCtD
Cefprozil—Neutropenia—Doxorubicin—kidney cancer	0.00151	0.00151	CcSEcCtD
Cefprozil—Diarrhoea—Vincristine—kidney cancer	0.00149	0.00149	CcSEcCtD
Cefprozil—Pain—Paclitaxel—kidney cancer	0.00148	0.00148	CcSEcCtD
Cefprozil—Pruritus—Gemcitabine—kidney cancer	0.00147	0.00147	CcSEcCtD
Cefprozil—Nausea—Dactinomycin—kidney cancer	0.00145	0.00145	CcSEcCtD
Cefprozil—Dizziness—Vincristine—kidney cancer	0.00144	0.00144	CcSEcCtD
Cefprozil—Drowsiness—Doxorubicin—kidney cancer	0.00144	0.00144	CcSEcCtD
Cefprozil—Confusional state—Capecitabine—kidney cancer	0.00143	0.00143	CcSEcCtD
Cefprozil—Feeling abnormal—Paclitaxel—kidney cancer	0.00143	0.00143	CcSEcCtD
Cefprozil—Stevens-Johnson syndrome—Doxorubicin—kidney cancer	0.00143	0.00143	CcSEcCtD
Cefprozil—Gastrointestinal pain—Paclitaxel—kidney cancer	0.00142	0.00142	CcSEcCtD
Cefprozil—Diarrhoea—Gemcitabine—kidney cancer	0.00142	0.00142	CcSEcCtD
Cefprozil—Thrombocytopenia—Capecitabine—kidney cancer	0.00139	0.00139	CcSEcCtD
Cefprozil—Vomiting—Vincristine—kidney cancer	0.00139	0.00139	CcSEcCtD
Cefprozil—Urticaria—Paclitaxel—kidney cancer	0.00138	0.00138	CcSEcCtD
Cefprozil—Rash—Vincristine—kidney cancer	0.00138	0.00138	CcSEcCtD
Cefprozil—Dermatitis—Vincristine—kidney cancer	0.00138	0.00138	CcSEcCtD
Cefprozil—Body temperature increased—Paclitaxel—kidney cancer	0.00137	0.00137	CcSEcCtD
Cefprozil—Abdominal pain—Paclitaxel—kidney cancer	0.00137	0.00137	CcSEcCtD
Cefprozil—Headache—Vincristine—kidney cancer	0.00137	0.00137	CcSEcCtD
Cefprozil—Agranulocytosis—Doxorubicin—kidney cancer	0.00134	0.00134	CcSEcCtD
Cefprozil—Vomiting—Gemcitabine—kidney cancer	0.00132	0.00132	CcSEcCtD
Cefprozil—Rash—Gemcitabine—kidney cancer	0.00131	0.00131	CcSEcCtD
Cefprozil—Dermatitis—Gemcitabine—kidney cancer	0.0013	0.0013	CcSEcCtD
Cefprozil—Haemoglobin—Doxorubicin—kidney cancer	0.0013	0.0013	CcSEcCtD
Cefprozil—Headache—Gemcitabine—kidney cancer	0.0013	0.0013	CcSEcCtD
Cefprozil—Nausea—Vincristine—kidney cancer	0.0013	0.0013	CcSEcCtD
Cefprozil—Haemorrhage—Doxorubicin—kidney cancer	0.00129	0.00129	CcSEcCtD
Cefprozil—Insomnia—Capecitabine—kidney cancer	0.00129	0.00129	CcSEcCtD
Cefprozil—Pharyngitis—Doxorubicin—kidney cancer	0.00128	0.00128	CcSEcCtD
Cefprozil—Hypersensitivity—Paclitaxel—kidney cancer	0.00128	0.00128	CcSEcCtD
Cefprozil—Nausea—Gemcitabine—kidney cancer	0.00123	0.00123	CcSEcCtD
Cefprozil—Pruritus—Paclitaxel—kidney cancer	0.00123	0.00123	CcSEcCtD
Cefprozil—Erythema multiforme—Doxorubicin—kidney cancer	0.00122	0.00122	CcSEcCtD
Cefprozil—Pain—Capecitabine—kidney cancer	0.00122	0.00122	CcSEcCtD
Cefprozil—Diarrhoea—Paclitaxel—kidney cancer	0.00119	0.00119	CcSEcCtD
Cefprozil—Feeling abnormal—Capecitabine—kidney cancer	0.00117	0.00117	CcSEcCtD
Cefprozil—Gastrointestinal pain—Capecitabine—kidney cancer	0.00116	0.00116	CcSEcCtD
Cefprozil—Dizziness—Paclitaxel—kidney cancer	0.00115	0.00115	CcSEcCtD
Cefprozil—Urticaria—Capecitabine—kidney cancer	0.00113	0.00113	CcSEcCtD
Cefprozil—Body temperature increased—Capecitabine—kidney cancer	0.00112	0.00112	CcSEcCtD
Cefprozil—Abdominal pain—Capecitabine—kidney cancer	0.00112	0.00112	CcSEcCtD
Cefprozil—Erythema—Doxorubicin—kidney cancer	0.00112	0.00112	CcSEcCtD
Cefprozil—Tension—Doxorubicin—kidney cancer	0.0011	0.0011	CcSEcCtD
Cefprozil—Vomiting—Paclitaxel—kidney cancer	0.0011	0.0011	CcSEcCtD
Cefprozil—Rash—Paclitaxel—kidney cancer	0.00109	0.00109	CcSEcCtD
Cefprozil—Dermatitis—Paclitaxel—kidney cancer	0.00109	0.00109	CcSEcCtD
Cefprozil—Nervousness—Doxorubicin—kidney cancer	0.00109	0.00109	CcSEcCtD
Cefprozil—Headache—Paclitaxel—kidney cancer	0.00109	0.00109	CcSEcCtD
Cefprozil—Hypersensitivity—Capecitabine—kidney cancer	0.00105	0.00105	CcSEcCtD
Cefprozil—Agitation—Doxorubicin—kidney cancer	0.00103	0.00103	CcSEcCtD
Cefprozil—Nausea—Paclitaxel—kidney cancer	0.00103	0.00103	CcSEcCtD
Cefprozil—Pruritus—Capecitabine—kidney cancer	0.00101	0.00101	CcSEcCtD
Cefprozil—Convulsion—Doxorubicin—kidney cancer	0.000974	0.000974	CcSEcCtD
Cefprozil—Diarrhoea—Capecitabine—kidney cancer	0.000974	0.000974	CcSEcCtD
Cefprozil—Dizziness—Capecitabine—kidney cancer	0.000941	0.000941	CcSEcCtD
Cefprozil—Confusional state—Doxorubicin—kidney cancer	0.000925	0.000925	CcSEcCtD
Cefprozil—Anaphylactic shock—Doxorubicin—kidney cancer	0.000917	0.000917	CcSEcCtD
Cefprozil—Vomiting—Capecitabine—kidney cancer	0.000905	0.000905	CcSEcCtD
Cefprozil—Thrombocytopenia—Doxorubicin—kidney cancer	0.000898	0.000898	CcSEcCtD
Cefprozil—Rash—Capecitabine—kidney cancer	0.000897	0.000897	CcSEcCtD
Cefprozil—Dermatitis—Capecitabine—kidney cancer	0.000896	0.000896	CcSEcCtD
Cefprozil—Headache—Capecitabine—kidney cancer	0.000891	0.000891	CcSEcCtD
Cefprozil—Nausea—Capecitabine—kidney cancer	0.000845	0.000845	CcSEcCtD
Cefprozil—Insomnia—Doxorubicin—kidney cancer	0.00083	0.00083	CcSEcCtD
Cefprozil—Somnolence—Doxorubicin—kidney cancer	0.000815	0.000815	CcSEcCtD
Cefprozil—Pain—Doxorubicin—kidney cancer	0.000784	0.000784	CcSEcCtD
Cefprozil—Feeling abnormal—Doxorubicin—kidney cancer	0.000756	0.000756	CcSEcCtD
Cefprozil—Gastrointestinal pain—Doxorubicin—kidney cancer	0.00075	0.00075	CcSEcCtD
Cefprozil—Urticaria—Doxorubicin—kidney cancer	0.000729	0.000729	CcSEcCtD
Cefprozil—Abdominal pain—Doxorubicin—kidney cancer	0.000725	0.000725	CcSEcCtD
Cefprozil—Body temperature increased—Doxorubicin—kidney cancer	0.000725	0.000725	CcSEcCtD
Cefprozil—Hypersensitivity—Doxorubicin—kidney cancer	0.000676	0.000676	CcSEcCtD
Cefprozil—Pruritus—Doxorubicin—kidney cancer	0.000649	0.000649	CcSEcCtD
Cefprozil—Diarrhoea—Doxorubicin—kidney cancer	0.000628	0.000628	CcSEcCtD
Cefprozil—Dizziness—Doxorubicin—kidney cancer	0.000607	0.000607	CcSEcCtD
Cefprozil—Vomiting—Doxorubicin—kidney cancer	0.000583	0.000583	CcSEcCtD
Cefprozil—Rash—Doxorubicin—kidney cancer	0.000578	0.000578	CcSEcCtD
Cefprozil—Dermatitis—Doxorubicin—kidney cancer	0.000578	0.000578	CcSEcCtD
Cefprozil—Headache—Doxorubicin—kidney cancer	0.000575	0.000575	CcSEcCtD
Cefprozil—Nausea—Doxorubicin—kidney cancer	0.000545	0.000545	CcSEcCtD
